Since studies indicate that blockade of the PI3K pathway could enhance sensitivity to DNA-damaging treatments by suppressing NHEJ and HR repair [35], we hypothesized that the pan-PI3K inhibitor ZSTK474 may potentiate the cytotoxicity of TMZ in GBM cells. This evidence concerns the gene PIK3CB and glioblastoma.